Biosecurity in the Age of Synthetic Biology

Leyma Pérez De Haro

$124

Paperback

Forthcoming
Pre-Order now

QTY:

English

CRC Press
17 September 2024

Medicine: general issues; Molecular biology; Biotechnology; Industrial chemistry; Chemical engineering

Biosecurity in the Age of Synthetic Biology is a comprehensive review of the biosecurity issues faced by the innovative and rapidly evolving field of synthetic biology. This is a meticulous review of the groundbreaking biotechnological advancements and the critical need for robust biosecurity measures. The book provides an in-depth examination of the ethical, legal, and societal dimensions shaping the future of synthetic biology research, in addition to a practical protocol for biosecurity risk assessment. This is the first book to offer a structured guideline for biosecurity risk assessment in synthetic biology. The author’s balanced view of the opportunities of synthetic biology and the inherent security risks reveals foundational concepts, cutting-edge applications, and international perspectives on biosecurity. This essential guide illuminates scientific and technological frontiers and advocates for a proactive approach ensuring the responsible development and use of synthetic biology. It is an indispensable resource for scientists, policymakers, and anyone interested in the intersection of biotechnology and biosecurity.

Key Features:

Provides instructions and examples for a biosecurity risk assessment.

Includes detailed proposed outline for creating a Biosecurity Manual for broad adoption.

Emphasizes the future challenges and opportunities.

Offers insights on the role of artificial intelligence in synthetic biology and biosecurity.

By: Leyma Pérez De Haro
Imprint: CRC Press
Country of Publication: United Kingdom
Dimensions: Height: 234mm, Width: 156mm,
ISBN: 9781032725369
ISBN 10: 1032725362
Pages: 262
Publication Date: 17 September 2024
Audience: College/higher education , Professional and scholarly , Primary , Undergraduate
Format: Paperback
Publisher's Status: Forthcoming

Ch. 1 - The Case for Considering Biosecurity in Synthetic Biology. Ch. 2 - Synthetic Biology and Its Role in Biomedicine. Ch. 3 - Biosecurity Risks in Synthetic Biology. Ch. 4 - The Role of Artificial Intelligence (AI) in Synthetic Biology and Biosecurity Implications. Ch. 5 - Global Regulatory Frameworks and Policies for Synthetic Biology. Ch. 6 - Regulatory, Ethical, and Policy Considerations for Synthetic Biology. Ch. 7 - Biorisk Management in Synthetic Biology. Ch. 8 - Developing a Synthetic Biology Laboratory Biosecurity Manual. Ch. 9 - Incorporating Human Factors in Biosecurity for Synthetic Biology. Ch. 10 - Implementation of Biosecurity Measures in Different Settings. Ch. 11 - Conducting a Biosecurity Risk Assessment. Ch. 12 - Promoting Responsible Conduct in Biomedical Synthetic Biology. Ch. 13 - Ensuring a Safe Future in the Age of Synthetic Biology.

Dr. Leyma P. De Haro received a B.S. in Biochemistry from California State University, Los Angeles, and holds a Ph.D. in Biomedical Sciences from the University of New Mexico. She is a Registered Biosafety Professional (RBP) by ABSA International. She completed two postdoctoral fellowships, including one at Los Alamos National Laboratory. Dr. De Haro worked at Sandia National Laboratory, in the internationally renowned Global Chemical and Biological Security Team, where she specialized in Biosafety and Biosecurity on a global scale. She is currently part of the Biosafety Team at the California Institute of Technology. Dr. De Haro has over 14 years post Ph.D. experience as a scientist, helping laboratories and organizations enhance their biosafety and biosecurity practices. Her background in innovative scientific research enables her to understand the unique safety challenges laboratories and organizations face in today's rapidly evolving world of life sciences. With a keen focus on fostering a culture of responsibility and safety, Dr. De Haro is committed to promoting best practices in biosafety and biosecurity worldwide, supporting the life sciences community in pursuing groundbreaking discoveries and innovations.